David Arkowitz is Chief Financial Officer of Seres Therapeutics, Inc.. Currently has a direct ownership of 182,442 shares of MCRB, which is worth approximately $149,602. The most recent transaction as insider was on Feb 16, 2024, when has been sold 3,939 shares (Common Stock) at a price of $1.08 per share, resulting in proceeds of $4,254. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 182K
0% 3M change
3.8% 12M change
Total Value Held $149,602

David Arkowitz Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 16 2024
SELL
Open market or private sale
$4,254 $1.08 p/Share
3,939 Reduced 2.11%
182,442 Common Stock
Feb 15 2024
BUY
Exercise of conversion of derivative security
-
10,625 Added 5.39%
186,381 Common Stock
Oct 30 2023
SELL
Open market or private sale
$5,489 $1.35 p/Share
4,066 Reduced 2.26%
175,756 Common Stock
Oct 27 2023
BUY
Exercise of conversion of derivative security
-
13,209 Added 6.84%
179,822 Common Stock
Apr 27 2023
BUY
Grant, award, or other acquisition
-
42,500 Added 20.32%
166,613 Common Stock
Oct 27 2022
BUY
Grant, award, or other acquisition
-
42,500 Added 27.33%
112,992 Common Stock
Jul 05 2022
BUY
Grant, award, or other acquisition
$200,000 $3.15 p/Share
63,492 Added 49.22%
65,492 Common Stock
Jun 15 2022
BUY
Exercise of conversion of derivative security
-
5,000 Added 6.62%
70,492 Common Stock

Also insider at

FSTX
F-star Therapeutics, Inc. Healthcare
YMTX
YUMANITY THERAPEUTICS, INC. Healthcare
FLXN
Flexion Therapeutics Inc
DA

David Arkowitz

Chief Financial Officer
Cambridge, MA

Track Institutional and Insider Activities on MCRB

Follow Seres Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MCRB shares.

Notify only if

Insider Trading

Get notified when an Seres Therapeutics, Inc. insider buys or sells MCRB shares.

Notify only if

News

Receive news related to Seres Therapeutics, Inc.

Track Activities on MCRB